Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16235789 | 0.86 | ALDH1A1 (0.33) | HTTMAPT | |
| SCHEMBL16234970 | 0.81 | ALDH1A1 (0.31) | MAPT | |
| SCHEMBL16235383 | 0.75 | HTT (0.33) | HTT | |
| SCHEMBL16235182 | 0.74 | AR (0.34) | HTTL3MBTL1MAPT | |
| SCHEMBL16235234 | 0.73 | FLT1 (0.38) | HTTL3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL16235389 | 0.71 | HTT (0.30) | HTTTRPV4 | |
| SCHEMBL30602330 | 0.69 | PGK1 (0.35) | HTTL3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL29130907 | 0.69 | PGK1 (0.35) | HTTL3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL16235303 | 0.69 | HTT (0.32) | HTT | |
| SCHEMBL16235287 | 0.69 | RAB9A (0.38) | HTTL3MBTL1TP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2925743-A1 | N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS | Active Biotech AB (SE) | 2015-10-07 | — | — | EP | disclosed |
| WO-2014184234-A1 | N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS | ACTIVE BIOTECH AB (SE) | 2014-11-20 | — | — | WO | disclosed |